ストックスクリーナーアプリを入手
3.29
2.17%
0.07
前日終値:
$3.22
開ける：
$3.19
24時間の取引高:
178.58K
Relative Volume:
0.37
時価総額：
$126.05M
収益：
$2.76M
当期純損益:
$-49.12M
株価収益率:
-2.1933
EPS:
-1.5
ネットキャッシュフロー:
$-46.21M
1週間 パフォーマンス:
+6.47%
1か月 パフォーマンス:
+6.47%
6か月 パフォーマンス:
-38.27%
1年 パフォーマンス:
-59.18%
1日の値動き範囲:
$3.06
$3.32
1週間の範囲:
$3.05
$3.32
52週間の値動き範囲:
$2.37
$8.17
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
OBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.29 | 123.37M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-20 | 開始されました | BTIG Research | Buy |
| 2025-01-02 | 開始されました | Barclays | Overweight |
| 2024-08-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | B. Riley Securities | Buy |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Metal.it
Orchestra BioMed Holdings Inc. Stock Analysis and ForecastOutstanding growth strategies - PrintWeekIndia
Is Orchestra BioMed Holdings Inc. a good long term investmentPhenomenal returns - PrintWeekIndia
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting - MSN
IFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
What drives Orchestra BioMed Holdings Inc. stock priceSuperior risk-adjusted returns - Autocar Professional
What analysts say about Orchestra BioMed Holdings Inc. stockRapid wealth multiplication - jammulinksnews.com
How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How To Trade (OBIO) - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN
Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN
Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st
Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener
Orchestra BioMed Confirms Director Elections and Auditor - TipRanks
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire
Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Trading Advice - news.stocktradersdaily.com
Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):